Selectivity and Mechanism of Action
The high toxicity of isoniazid toward Mycobacterium tuberculosis and its low toxicity for the human body are due to fundamental differences in their cellular structure. The key biochemical target of the drug is the synthesis process of mycolic acids. These acids act as a vital structural component of the mycobacterial cell wall. Since host (human) cells completely lack mycolic acids, the drug does not disrupt host cell metabolism, ensuring high selectivity of therapeutic action.
Pharmacokinetics and Distribution
The drug possesses excellent pharmacokinetic characteristics. When administered orally (via the gastrointestinal tract), it demonstrates high bioavailability and is well absorbed. Peak plasma concentration is reached within 1 to 4 hours post-administration.
Once in the systemic circulation, isoniazid is evenly distributed across all tissues and organs of the patient. A crucial property of the drug is its ability to easily cross various histohematic barriers. In particular, it freely crosses the blood-brain barrier (BBB), making it effective in central nervous system infections. Metabolites are excreted primarily through the kidneys.
Metabolism and Genetic Polymorphism
Biotransformation of the drug occurs in the liver via acetylation. Notably, the resulting acetylated form is pharmacologically inactive.
The rate of drug inactivation directly depends on the patient's genetic profile, specifically the activity of the N-acetyltransferase enzyme. There are two main patient groups:
- "Fast acetylators": in such patients, the elimination half-life is less than 1 hour. Due to the rapid degradation of the drug, higher doses are required to maintain a stable therapeutic concentration in the blood.
- "Slow acetylators": their elimination half-life is prolonged to approximately 3 hours. In this group, the risk of unwanted drug accumulation in the body (cumulation) increases significantly, leading to a higher incidence of side effects.
Clinical application and safety profile
Isoniazid is used for all known forms of tuberculosis. The primary route of administration is oral (per os). However, alternative routes can be used if necessary: intramuscular and intravenous injections, as well as rectal administration.
The spectrum of adverse drug reactions includes three main groups of complications: neurotoxicity, hepatotoxicity, and various allergic reactions.
To reduce toxic effects and prevent complications (providing "pharmacological cover"), the drug is obligatorily combined with the following agents:
- Vitamin $B_1$ (thiamine);
- Vitamin $B_6$ (pyridoxine);
- Glutamic acid.
The drug has strict contraindications. It must not be prescribed in epilepsy and susceptibility to seizures due to the high risk of precipitating convulsions. It is also contraindicated in liver dysfunction (due to pronounced hepatotoxicity) and renal impairment (as elimination occurs via the kidneys).
Other Drugs in the Group and Related Agents
Chemically, isoniazid is a derivative of isonicotinic acid hydrazide. The same pharmacological group includes drugs such as ftivazide, metazide, and opiniazid (also known as soluble saluzid).
In combination therapy for tuberculosis, rifampicin is frequently used. It is a semisynthetic antibiotic with a macrocyclic structure (belonging to the ansamycin group). Unlike isoniazid, which acts strictly specifically on mycobacteria, rifampicin has a broad spectrum of antimicrobial activity.
Briefly: answers to topical questions
What specific clinical manifestations of neurotoxicity are characteristic of isoniazid?
Clinical manifestations of isoniazid neurotoxicity include neuritis, optic neuropathy, and seizures. In polyneuropathy, initial signs are paresthesias, neuropathic pain, and decreased tactile and pain sensitivity in the fingers of the feet and/or hands. In the fully developed stage, the hypesthesia zone takes the shape of "socks" and/or "gloves", deep sensitivity decreases, tendon reflexes weaken or disappear completely, and flaccid atrophic paresis develops.
Why does vitamin B6 deficiency develop during isoniazid treatment?
Vitamin B6 deficiency during isoniazid treatment develops due to the drug interfering with vitamin B6 metabolism, leading to the depletion of the vitamin B6 pool. To prevent neurotoxicity when prescribing isoniazid, prophylactic administration of pyridoxine is recommended.
To remember the "covering" drugs that reduce isoniazid toxicity, use the PTG rule: Pyridoxine (vitamin $B_6$), Thiamine (vitamin $B_1$), Glutamic acid.
Class and exam questions
Why are patients prescribed different doses of isoniazid despite having the same body weight?
This is related to genetic polymorphism of metabolism. In "fast acetylators," the drug is broken down in less than an hour, requiring higher doses. In "slow acetylators," it lingers for up to three hours, increasing the risk of toxicity.
Why are B-complex vitamins included in the isoniazid treatment regimen?
Vitamins $B_1$ (thiamine) and $B_6$ (pyridoxine), as well as glutamic acid, are necessary for the prevention of severe complications. They act as "pharmacological cover," reducing the neurotoxic effect of the drug.
Can isoniazid be used in patients with epilepsy?
No, epilepsy and a predisposition to seizures are strict contraindications. The drug exhibits neurotoxicity and can provoke the onset of seizures.
What else to study on this topic
- Biochemical basis of the disruption of mycolic acid synthesis by isoniazid
- N-acetyltransferase genetic polymorphism: impact on pharmacokinetics
- Mechanisms of hepatotoxicity and neurotoxicity development in antituberculosis agents
- Comparative characteristics of isonicotinic acid hydrazide derivatives (ftivazide, metazide)
- Differences between highly specific isoniazid and broad-spectrum antibiotics (rifampicin)
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Isoniazid" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antibacterial Chemotherapeutic Agents"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.